Saturday 17 October 2026 Export TGTX’s income statement to Excel — free account

TG Therapeutics, Inc.

TG Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $616.3 million, up 87.3% from fiscal 2024. In the quarter to June 2026, revenue grew 70.3%, EPS fell 73.7%, free cash flow grew 427.1% and total debt rose 204.2%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

53.97 2.03 −3.63%

Follow TGTX

Alert me

Market cap: $8.6B
P/E: 17.8×
Fwd P/E: 29.4×
Dividend yield: —
F-score: 5/9
Altman Z: 6.29
Beneish M: 0.80
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	100.28%	112.60%	102.75%	111.96%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	5	4	4	4
ROA Full definition →	37.70%	42.27%	54.50%	55.55%
ROIC Full definition →	10.69%	11.48%	10.25%	8.91%
Return on Tangible Assets Full definition →	50.33%	51.33%	93.75%	101.02%
Average Days of Receivables Full definition →	183.32	204.32	181.01	182.11
Free Cash Flow per Share Full definition →	0.12	(0.10)	(0.17)	(0.48)
Free Cash Flow Full definition →	17.39	(14.19)	(24.99)	(70.24)
Capital Expenditures Full definition →	(0.49)	(0.24)	(0.21)	(0.17)
Other line items
Cash ROIC Full definition →	0.91%	(0.77%)	(2.41%)	(7.14%)
Accounts Receivable Turnover Full definition →	2.53	2.41	2.83	2.79
Accounts Payable Turnover Full definition →	0.81	0.84	1.21	0.73
Inventory Turnover Full definition →	0.93	0.83	0.85	0.67
Average Days of Payables Full definition →	553.42	457.76	389.62	525.86
Days of Inventory on Hand Full definition →	383.22	396.82	455.14	687.91
Tax Rate Full definition →	3.35	2.78	3.16	4.10
Research and Development Expense of Revenue Full definition →	28.05%	22.95%	26.00%	26.24%
Selling, General and Administrative Expense of Revenue Full definition →	37.27%	38.76%	37.65%	39.78%
Share Based Compensation of Revenue Full definition →	10.15%	9.94%	10.49%	11.46%
Interest Coverage Full definition →	3.64	5.41	4.61	3.79
Operating CF/Net income Full definition →	0.04	(0.03)	(0.06)	(0.16)
Depreciation/Fixed assets Full definition →	0.00	0.00	0.00	0.00
Capex/Depreciation Full definition →	1.42	0.18	0.09	0.05
Revenue per Share Full definition →	5.64	4.85	4.27	3.66
Operating CF per Share Full definition →	0.13	(0.10)	(0.17)	(0.48)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly